Inactive Instrument

Other languages Satsuma Pharmaceuticals, Inc.

Equities

STSA

US80405P1075

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Satsuma Pharmaceuticals, Inc. Receives Complete Response Letter from the U.S. Food and Drug Administration	Jan. 17
Insider Buy: Satsuma Pharmaceuticals	23-06-08
Satsuma Pharmaceuticals, Inc. Announces CEO Changes	23-06-08
Satsuma Pharmaceuticals, Inc. Announces Board Changes	23-06-08
Shin Nippon Biomedical Laboratories, Ltd. completed the acquisition of the remaining 91.6% stake in Satsuma Pharmaceuticals, Inc. from a group of sellers.	23-06-07
Satsuma Pharmaceuticals' New Drug Application for Migraine Treatment Accepted for FDA Review	23-05-18
Satsuma Pharmaceuticals, Inc. Announces FDA Acceptance of 505(b)(2) New Drug Application for STS101	23-05-18
Satsuma Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11
Sector Update: Health Care Stocks Higher Premarket Monday	23-04-17
Bank Earnings in Focus as US Equity Futures Tread Water	23-04-17
Top Premarket Gainers	23-04-17
Satsuma Pharmaceuticals to be Acquired by Shin Nippon Biomedical	23-04-17
Satsuma Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-28
Satsuma Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-28
Satsuma Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt	23-03-27
Satsuma Pharmaceuticals, Inc. Provides an Update on Its STS101 Development Program and Corporate Update	22-12-20
Satsuma Pharmaceuticals, Inc. Announces the Results of Phase 3 Clinical Studies for STS101	22-11-24
Insider Buy: Satsuma Pharmaceuticals	22-11-23
Insider Buy: Satsuma Pharmaceuticals	22-11-16
Sector Update: Health Care Stocks Hanging on for Monday Gains	22-11-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Satsuma Pharmaceuticals, Inc.

Equities

STSA

US80405P1075

Other languages

Filters